SCHEMBL4579765

SCHEMBL4579765

NS(=O)(=O)c1ccc(NC(=O)C(=O)N2CCC(Cc3ccc(F)cc3)CC2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.62
KMT2A Q03164 2/20 0.62
DUSP3 P51452 1/20 0.62
PTPN5 P54829 1/20 0.62
PTPN11 Q06124 1/20 0.62
GRIN1 Q05586 5/20 0.62
GRIN2B Q13224 5/20 0.62
GRIN2D O15399 3/20 0.62
GRIN3B O60391 3/20 0.62
GRIN2A Q12879 3/20 0.62
GRIN2C Q14957 3/20 0.62
GRIN3A Q8TCU5 3/20 0.62
CA1 P00915 6/20 0.54
CA2 P00918 6/20 0.54
CA9 Q16790 6/20 0.54
CA12 O43570 5/20 0.53
CA7 P43166 2/20 0.53
CA14 Q9ULX7 1/20 0.53
ALDH1A1 P00352 2/20 0.52
GAA P10253 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4578149 0.89 KMT2A (0.74) MEN1KMT2ADUSP3PTPN5PTPN11
SCHEMBL4577199 0.87 GRIN1 (0.66) GRIN1GRIN2BGRIN2DGRIN3BGRIN2A
SCHEMBL4410948 0.85 GRIN1 (0.78) GRIN1GRIN2BGRIN2DGRIN3BGRIN2A
SCHEMBL4578087 0.85 GRIN1 (0.62) GRIN1GRIN2BGRIN2DGRIN3BGRIN2A
SCHEMBL4576699 0.84 GRIN1 (0.66) GRIN1GRIN2BGRIN2DGRIN3BGRIN2A
SCHEMBL4578497 0.84 GRIN1 (0.66) GRIN1GRIN2BGRIN2DGRIN3BGRIN2A
SCHEMBL4578396 0.83 CCR3 (0.64) MEN1KMT2AGRIN1GRIN2BGRIN2D
SCHEMBL4579066 0.83 GRIN1 (0.64) GRIN1GRIN2BGRIN2DGRIN3BGRIN2A
SCHEMBL22351983 0.82 GRIN1 (0.66) GRIN1GRIN2BGRIN2DGRIN3BGRIN2A
SCHEMBL4577502 0.82 KMT2A (0.63) MEN1KMT2AGRIN1GRIN2BGRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7435744-B2 Piperidine derivatives as NMDA receptor antagonists GEDEON RICHTER VEGYESZETI GYAR RT (HU) 2008-10-14 US disclosed
US-20040157886-A1 Piperdine derivatives as NMDA receptor antagonists UCB Biopharma SRL (BE) 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157886-A1 Piperdine derivatives as NMDA receptor antagonists GRIN1, GRIN2D, GRIN2C MEN1 2584/4885KMT2A 1234/4885DUSP3 3794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.